Gatifloxacin clinical trials
Also written Zymar.
How each study uses Gatifloxacin is sorted by a rule, right about nine times in ten. Readers can ask us to read every study one by one.Ask us to read each study
Approvals
The first approval found in each region, with its record
- United States
- 28 Mar 2003 · ZYMAR · NDA 021493 (FDA, Drugs@FDA)
- European Union
- Not in EMA's list of EU-wide authorizations
From FDA's Drugs@FDA and Purple Book (through openFDA) and the European Medicines Agency, files of Sept 2026 and 27 Oct 2026. National approvals in Europe and other countries are not included. How this is worked out
How studies write it
Studies that test it under each name
Studies by the year they started
13 studies that test it; most in 2007 (4)
| Year | Studies |
|---|---|
| 2003 | 1 |
| 2004 | 1 |
| 2006 | 1 |
| 2007 | 4 |
| 2008 | 3 |
| 2009 | 1 |
| 2011 | 1 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
What it is tested for
Each study’s main condition, where its own words name it, so a study counts once.
Who runs them
Industry 6 · Other 8
Allergan (5) · Stanford University (3) · National Institute of Allergy and Infectious Diseases (NIAID) (1) · Oxford University Clinical Research Unit, Vietnam (1) · Walter Reed Army Medical Center (1) · Santen Inc. (1) · Cornea Consultants Of Nashville (1) · Queen's University (1)
Often tested with
Tested in the same studies.
Moxifloxacin (6) · Levofloxacin (2) · Linezolid (1) · Ceftriaxone (1) · Besifloxacin (1)
Studies
Open first, then newest update. How each study uses Gatifloxacin is read from its arms, and is right about nine times in ten. Ask us to read each study. These are the studies that list it as an intervention; a search of ClinicalTrials.gov also finds studies that mention it only in a description, such as earlier treatment.
Testing it · 14
- A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedPhase 3AllerganNCT00518089Written as Gatifloxacin 0.5% eye dropsHow we know
- Early Bactericidal Activity of Linezolid, Gatifloxacin, Levofloxacin, Isoniazid (INH) and Moxifloxacin in HIV Negative Adults With Initial Episodes of Sputum Smear-Positive Pulmonary TuberculosisCompletedPhase 1/2National Institute of Allergy and Infectious Diseases (NIAID)NCT00396084Written as GatifloxacinHow we know
- Preoperative Topical Gatifloxacin on Anterior Chamber Cultures After Cataract SurgeryWithdrawnNot applicableQueen's UniversityNCT00335231Written as gatifloxacin ophthalmic (ZYMAR)How we know
- Topical Antibiotics and Intravitreous InjectionsCompletedPhase 4Stanford UniversityNCT00410891Written as gatifloxacinHow we know
- Gatifloxacin Versus Ceftriaxone in the Treatment of Enteric FeverCompletedPhase 4Oxford University Clinical Research Unit, VietnamNCT01421693Written as GatifloxacinHow we know
- A Comparison of Three Fluoroquinolone Topical Eyedrops in the Treatment of Infectious Corneal Ulcers.TerminatedPhase 2Cornea Consultants Of NashvilleNCT01928693Written as Zymaxid 0.5% Ophthalmic SolutionHow we know
- One Hour Preoperative GatifloxacinCompletedPhase 4Stanford UniversityNCT00350363Written as ZymarHow we know
- Comparison of the Effect of 4th Generation Fluoroquinolones, Gatifloxacin and Moxifloxacin, on Epithelial Healing Following Photorefractive Keratectomy (PRK), A Substudy of: Initial Evaluation of Excimer Laser Keratorefractive Surgery in U.S. Army Personnel (WU # 2335-99)CompletedNot applicableWalter Reed Army Medical CenterNCT00414011Written as GatifloxacinHow we know
- Prospective Randomized Comparison of Zymar(Gatifloxacin) and Vigamox (Moxifloxacin) in Killing Conjunctival Bacterial Flora Following a One-hour ApplicationWithdrawnNot applicableStanford UniversityNCT00466570Written as gatifloxacin, moxifloxacinHow we know
- A Clinical Study to Evaluate if Benzalkonium Chloride (BAK) in a Quinolone Eyedrop Reduces the Likelihood of Developing Resistant OrganismsCompletedPhase 4AllerganNCT00874887Written as gatifloxacin ophthalmic solution 0.3%How we know
- A Study of the Safety and Efficacy of Gatifloxacin in Patients With Bacterial ConjunctivitisCompletedPhase 3AllerganNCT00509873Written as Gatifloxacin 0.5% eye dropsHow we know
- A Study to Evaluate the Safety and Efficacy of Gatifloxacin for the Treatment of Bacterial ConjunctivitisCompletedPhase 4AllerganNCT00464438Written as gatifloxacinHow we know
- Ocular Availability in Human Tears After Topical Administration of 1.5% Levofloxacin Compared to Active ComparatorsCompletedPhase 4Santen Inc.NCT00703313Written as 0.3% gatifloxacin ophthalmic solutionHow we know
- Safety and Efficacy Study of Gatifloxacin Compared With Ciprofloxacin in Patients With Acute Bacterial Corneal UlcersCompletedPhase 2AllerganNCT00651586Written as Gatifloxacin 0.3% ophthalmic solutionHow we know
As the comparator · 6 — what is tested is compared with Gatifloxacin
- Efficacy of the Ophthalmic Pazufloxacin 0.6% for Bacterial Conjunctivitis, Compared to Gatifloxacin 0.3%.TerminatedPhase 3Laboratorios Sophia S.A de C.V.NCT03696342Written as ZymarHow we know
- Safety and Efficacy of PRO-157 vs Moxifloxacin vs Gatifloxacin in Patients With Bacterial Conjunctivitis (Pazufloxacin)CompletedPhase 2Laboratorios Sophia S.A de C.V.NCT02980523Written as Zymar®How we know
- Non-Inferiority of Gatifloxacin/Prednisolone Association vs Isolated Administration in Prevention of Ocular Infection/InflammationCompletedPhase 3Federal University of São PauloNCT01218737Written as isolated 0.3% gatifloxacin and 1.0% prednisolone acetateHow we know
- Besifloxacin Ophthalmic Suspension Verses Gatifloxacin Ophthalmic Solution in Neonates With Bacterial ConjunctivitisTerminatedPhase 3Bausch & Lomb IncorporatedNCT01330355Written as GatifloxacinHow we know
- Assessment of the Concentrations of Besifloxacin, Moxifloxacin, or Gatifloxacin in the Aqueous Humor of SubjectsCompletedPhase 1Bausch & Lomb IncorporatedNCT00824070Written as gatifloxacinHow we know
- Concentration of Besifloxacin, Gatifloxacin, and Moxifloxacin in Human Conjunctiva After Topical InstillationCompletedPhase 1Bausch & Lomb IncorporatedNCT00905762Written as GatifloxacinHow we know
Codes
What other systems call Gatifloxacin · ClinicalTrials.gg INT006798
- MeSH (NLM) D000077734GatifloxacinConfirmed ClinicalTrials.gov, NLM
- UNII (FDA) L4618BD7KJGATIFLOXACINConfirmed FDA, NLM
- RxNorm 228476One source FDA
- NCI Thesaurus C29070GatifloxacinOne source FDA
| System | Code | Name there | Checked by |
|---|---|---|---|
| MeSH (NLM) | D000077734 | Gatifloxacin | Confirmed ClinicalTrials.gov, NLM |
| UNII (FDA) | L4618BD7KJ | GATIFLOXACIN | Confirmed FDA, NLM |
| RxNorm | 228476 | — | One source FDA |
| NCI Thesaurus | C29070 | Gatifloxacin | One source FDA |
“Confirmed” means two independent publishers link the code to this drug; “one source”, one does and its name agrees.